SYNAPLIN Trademark

Trademark Overview

On Wednesday, February 13, 2008, a trademark application was filed for SYNAPLIN with the United States Patent and Trademark Office. The USPTO has given the SYNAPLIN trademark a serial number of 77395862. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, September 19, 2011. This trademark is owned by Biogen Idec MA Inc.. The SYNAPLIN trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for use in the treatment of autoimmune disorders, neurological disorders, cardiovascular disorders, oncological disorders, multiple sclerosis, Crohn's disease, rheumatoid arthritis, concerning host-vs-graft or graft-vs-host reaction and mitochondrial diseases transplant rejection
synaplin

General Information

Serial Number77395862
Word MarkSYNAPLIN
Filing DateWednesday, February 13, 2008
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, September 19, 2011
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, May 27, 2008

Trademark Statements

Goods and ServicesPharmaceutical preparations for use in the treatment of autoimmune disorders, neurological disorders, cardiovascular disorders, oncological disorders, multiple sclerosis, Crohn's disease, rheumatoid arthritis, concerning host-vs-graft or graft-vs-host reaction and mitochondrial diseases transplant rejection

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, February 19, 2008
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameBiogen Idec MA Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressWeston, MA 02493
Party NameBiogen Idec MA Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressCambridge, MA 02142

Trademark Events

Event DateEvent Description
Monday, September 19, 2011ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
Monday, September 19, 2011ABANDONMENT - NO USE STATEMENT FILED
Wednesday, February 23, 2011NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, February 22, 2011EXTENSION 5 GRANTED
Wednesday, February 16, 2011EXTENSION 5 FILED
Wednesday, February 16, 2011TEAS EXTENSION RECEIVED
Tuesday, August 17, 2010NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, August 16, 2010EXTENSION 4 GRANTED
Monday, August 9, 2010EXTENSION 4 FILED
Monday, August 9, 2010TEAS EXTENSION RECEIVED
Tuesday, July 6, 2010APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Tuesday, July 6, 2010TEAS CHANGE OF OWNER ADDRESS RECEIVED
Tuesday, March 2, 2010EXTENSION 3 GRANTED
Wednesday, February 10, 2010EXTENSION 3 FILED
Wednesday, February 10, 2010TEAS EXTENSION RECEIVED
Wednesday, August 19, 2009EXTENSION 2 GRANTED
Tuesday, August 18, 2009EXTENSION 2 FILED
Tuesday, August 18, 2009TEAS EXTENSION RECEIVED
Tuesday, February 17, 2009EXTENSION 1 GRANTED
Tuesday, February 3, 2009EXTENSION 1 FILED
Tuesday, February 17, 2009CASE ASSIGNED TO INTENT TO USE PARALEGAL
Tuesday, February 3, 2009TEAS EXTENSION RECEIVED
Tuesday, August 19, 2008NOA MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, May 27, 2008PUBLISHED FOR OPPOSITION
Wednesday, May 7, 2008NOTICE OF PUBLICATION
Tuesday, April 22, 2008LAW OFFICE PUBLICATION REVIEW COMPLETED
Tuesday, April 22, 2008ASSIGNED TO LIE
Thursday, April 17, 2008APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, April 11, 2008ASSIGNED TO EXAMINER
Tuesday, February 19, 2008NEW APPLICATION ENTERED IN TRAM

Related Keywords

synaplin disorders graft host concerning arthritis reaction mitochondrial rejection transplant diseases